Validating the Children's Depression Inventory in the Context of Rwanda
Overview
Authors
Affiliations
Background: Depression is often co-morbid with chronic conditions, and when combined with HIV it can increase progression and reduce survival. A brief and accurate screening tool for depression among children living with HIV is necessary to increase access to mental health care and improve HIV-related outcomes in the long-term.
Methods: A validation study was conducted, comparing the Children's Depression Inventory (CDI) with a structured clinical assessment as the gold standard among children living with HIV ages 7-14 years in Rwanda. The response rate was 87 % and the analysis was performed among 100 study participants.
Results: Twenty-five percent of children had a diagnosis of depression based on the clinical interview. Sensitivity of the CDI ranged from 44 to 76 % and specificity was 92 to 100 % for cut-off scores from 5 to 9. The area under the curve (AUC) for receiver operating characteristic analysis, an estimate of overall accuracy, was 0.87 (95 % confidence interval: 0.77 - 0.97).
Conclusions: The significant prevalence of depression among children living with HIV in Rwanda reflects a critical need to advance mental health care in this population. Although overall accuracy of the CDI is reasonable in this context, further research needs to be done to develop a more sensitive measure of depression in this vulnerable population. Development of a highly sensitive screening measure will be a fundamental step towards improving access to mental health care among children living with HIV, potentially improving health outcomes and quality of life in the long-term as this vulnerable population transitions into adulthood.
Mpango R, Ssembajjwe W, Rukundo G, Taylor Salisbury T, Levin J, Gadow K Psychiatry J. 2022; 2022:8975704.
PMID: 35572346 PMC: 9098297. DOI: 10.1155/2022/8975704.
Adolescent Motherhood and HIV in South Africa: Examining Prevalence of Common Mental Disorder.
Roberts K, Smith C, Cluver L, Toska E, Zhou S, Boyes M AIDS Behav. 2021; 26(4):1197-1210.
PMID: 34570313 PMC: 8940800. DOI: 10.1007/s10461-021-03474-8.
Enane L, Apondi E, Aluoch J, Bakoyannis G, Kulzer J, Kwena Z PLoS One. 2021; 16(9):e0257210.
PMID: 34506555 PMC: 8432853. DOI: 10.1371/journal.pone.0257210.
Binagwaho A, Remera E, Bayingana A, Gishoma D, Scott K, Goosman M BMC Pediatr. 2021; 21(1):59.
PMID: 33514343 PMC: 7844907. DOI: 10.1186/s12887-020-02475-1.
Olashore A, Paruk S, Akanni O, Tomita A, Chiliza B AIDS Behav. 2020; 25(6):1711-1728.
PMID: 33216245 DOI: 10.1007/s10461-020-03100-z.